| RS1416911485 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS141691317 |
MED12L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1416924105 |
PLA2G6
|
Health Risk |
Likely pathogenic |
PLA2G6-associated neurodegeneration, PLA2G6-associated neurodegeneration |
| RS141692693 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, 3M syndrome 1 |
| RS141693578 |
MEOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
MEOX1-related disorder, MEOX1-related disorder |
| RS141694326 |
NLRP7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydatidiform mole, recurrent |
| RS141695023 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS141695705 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1416960576 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS141696191 |
POC5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141696914 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Usher syndrome type 2A |
| RS1416969857 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS141697267 |
TECPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 49, Inborn genetic diseases |
| RS1416973473 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS141698221 |
TUBB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia, isolated |
| RS141698427 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS141698692 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS1416988044 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS141698985 |
IL7R
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Immunodeficiency 104 |
| RS141699123 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1417000465 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS141701364 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Inborn genetic diseases |
| RS1417019207 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1417020694 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS141702094 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1417025395 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS141702885 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1417035592 |
ARID1B
|
Health Risk |
Pathogenic |
Intellectual disability, Coffin-Siris syndrome 1 |
| RS1417036453 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Cardiovascular phenotype |
| RS141703746 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS141704101 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS141704244 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1417046088 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1417046511 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, APC-Associated Polyposis Disorders |
| RS141704823 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
C5-related disorder, Colon adenocarcinoma |
| RS141705276 |
KIAA1549
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS141705330 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Corneal dystrophy-perceptive deafness syndrome |
| RS1417057515 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS141706094 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis |
| RS141706152 |
TENM4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1417062461 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS141706561 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, Retinal dystrophy |
| RS141706688 |
CNTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS141706767 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS141707292 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS141707567 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 10 |
| RS141707850 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS1417082178 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS141708238 |
COMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS141708554 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 4, Nephronophthisis 12 |
| RS1417088430 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS1417089374 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS141709096 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal acantholytic epidermolysis bullosa, Woolly hair-skin fragility syndrome |
| RS141709685 |
GLE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal congenital contracture syndrome 1 |
| RS141710153 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Inborn genetic diseases |
| RS1417111404 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Isolated focal cortical dysplasia type II |
| RS141711342 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1417119878 |
GDF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS141712104 |
VSX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 2, Microphthalmia |
| RS1417121666 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Progressive familial heart block type IB |
| RS141713197 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ANK3-related disorder |
| RS1417145000 |
TMTC3
|
Health Risk |
Pathogenic |
— |
| RS1417146153 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS141715004 |
SLC9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1417151403 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 5A |
| RS141715248 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS141715606 |
L2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS141715950 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS141716537 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS141716975 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS141717050 |
STXBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis |
| RS1417172313 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1417174086 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1417174760 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1417177018 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS141717814 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS141717966 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1417182811 |
COL11A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Otospondylomegaepiphyseal dysplasia, autosomal dominant |
| RS141718442 |
SOX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1417184535 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, ABCA4-related retinopathy |
| RS141718495 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Kleefstra syndrome 2 |
| RS1417190414 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1417190717 |
ATR
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS141719183 |
PLEKHG3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS141719745 |
ERCC6L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancytopenia-developmental delay syndrome, Inborn genetic diseases |
| RS141720146 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1417203331 |
OBSCN
|
Health Risk |
Pathogenic |
— |
| RS141720633 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, 7 conditions |
| RS141720810 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS141721173 |
SERPINH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 10, Preterm premature rupture of membranes |
| RS1417213536 |
HGD
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkaptonuria, Alkaptonuria |
| RS141721605 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 4, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1417217555 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS1417219341 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1417226023 |
DEAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS141722672 |
BAAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Bile acid conjugation defect 1, BAAT-related disorder |
| RS1417230303 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS141723499 |
LIAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipoic acid synthetase deficiency, Inborn genetic diseases |
| RS141723617 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS1417236940 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
NSD1-related disorder, Inborn genetic diseases |